Volume 272, Number 2,
Issue of January 10, 1997
pp. 875-882
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Regulation of Src Homology 2-containing Tyrosine Phosphatase 1 during Activation of Human Neutrophils
ROLE OF PROTEIN KINASE C
(Received for publication, April 19, 1996, and in revised form, October 16, 1996)
John H.
Brumell
§
,
Chi Kin
Chan
,
Jeffrey
Butler
,
Niels
Borregaard
**
,
Katherine A.
Siminovitch


§§¶¶
,
Sergio
Grinstein
§
and
Gregory P.
Downey
From the
Division of Cell Biology, Research
Institute, Hospital for Sick Children,
Toronto, Ontario M5G-1X8, Canada, Departments of
§ Biochemistry,
Medicine,
§§ Immunology, and ¶¶ Molecular and
Medical Genetics, University of Toronto,
Toronto, Ontario M5S-1A8, Canada, ** Granulocyte Research Laboratory,
Department of Haematology L, Rigshospitalet, Copenhagen DK-2100,
Denmark, 
Samuel Lunenfeld Research
Institute, Mount Sinai Hospital, Toronto, Ontario M5G-1X5, Canada,
and c Respiratory Division, Toronto Hospital, Toronto, Ontario
M5G 2C4, Canada
The tyrosine phosphorylation of several proteins
induced in neutrophils by soluble and particulate stimuli is thought to
be crucial for initiating antimicrobial responses. Although activation of tyrosine kinases is thought to mediate this event, the role of
tyrosine phosphatases in the initiation and modulation of neutrophil responses remains largely undefined. We investigated the role of Src
homology 2-containing tyrosine phosphatase 1 (SHP-1; also known as
protein tyrosine phosphatase 1C (PTP1C), hematopoetic cell phosphatase,
PTP-N6, and SHPTP-1), a phosphatase expressed primarily in hemopoietic
cells, in the activation of human neutrophils. SHP-1 mRNA and
protein were detected in these cells, and the enzyme was found to be
predominantly localized to the cytosol in unstimulated cells. Following
stimulation with neutrophil agonists such as phorbol ester, chemotactic
peptide, or opsonized zymosan, a fraction of the phosphatase
redistributed to the cytoskeleton. Agonist treatment also induced
significant decreases (30-60%) in SHP-1 activity, which correlated
temporally with increases in the cellular phosphotyrosine content.
Phosphorylation of SHP-1 on serine residues was associated with the
inhibition of its enzymatic activity, suggesting a causal relationship.
Accordingly, both the agonist-evoked phosphorylation of SHP-1 and the
inhibition of its catalytic activity were blocked by treatment with
bisindolylmaleimide I, a potent and specific inhibitor of protein
kinase C (PKC) activity. Immunoprecipitated SHP-1 was found to be
phosphorylated efficiently by purified PKC in vitro. Such
phosphorylation also caused a decrease in the phosphatase activity of
SHP-1. Together, these data suggest that inhibition of SHP-1 by
PKC-mediated serine phosphorylation plays a role in facilitating the
accumulation of tyrosine-phosphorylated proteins following neutrophil
stimulation. These findings provide a new link between the PKC and
tyrosine phosphorylation branches of the signaling cascade that
triggers antimicrobial responses in human neutrophils.